Xiaoqing Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiaoqing Xu has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Chang Qu
Department of General Surgery, Xuanwu Hospital, Capital Medical University, No.45 Changchun Street, Beijing, China
3 shared publications- Fei Li
Department of General Surgery, Xuanwu Hospital, Capital Medical University
3 shared publications Wentong Mei
Department of General Surgery, Xuanwu Hospital, Capital Medical University, No.45 Changchun Street, Beijing, China; Department of Gastrointestinal Surgery, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
3 shared publicationsJia Li
Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
2 shared publicationsJiaying Song
Department of Immunology, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100005, China
2 shared publicationsJie Li
Department of General Surgery, Xuanwu Hospital, Capital Medical University, No.45 Changchun Street, Beijing, China
2 shared publications
Latest Publications
- Open Access
- 6 November 2025
- Published by Elsevier in Journal of Advanced Research
- Vol. 86, 543-557
The aryl hydrocarbon receptor inhibits antigen presentation to promote progression of pancreatic ductal adenocarcinoma
- 6 November 2025
- Published by Elsevier in Journal of Advanced Research
- Vol. 86, 543-557
Open AccessThe aryl hydrocarbon receptor inhibits antigen presentation to promote progression of pancreatic ductal adenocarcinoma
- 29 May 2025
- Published by Elsevier in Immunology Letters
- Vol. 276, 107047
DUSP14 attenuates airway inflammation and mucus hypersecretion in allergic asthma by regulating TAK1 activity
- 29 May 2025
- Published by Elsevier in Immunology Letters
- Vol. 276, 107047
DUSP14 attenuates airway inflammation and mucus hypersecretion in allergic asthma by regulating TAK1 activity
- Open Access
- 3 July 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1401056
Unravelling the role of gut microbiota in acute pancreatitis: integrating Mendelian randomization with a nested case–control study
Background: Gut microbiota may influence the development of acute pancreatitis (AP), a serious gastrointestinal disease with high morbidity and mortality. This study aimed to identify a causal link by investigating the relationship between gut microbiota and AP.Methods: Mendelian randomization (MR) and a nested case–control study were used to explore associations between gut microbiota composition and AP. 16S rRNA sequencing, random forest modelling (RF), support vector machine (SVM), and Kaplan–Meier survival analysis was applied to identify significant gut microbiota and their correlation with hospitalization duration in AP patients.Results: Bidirectional MR results confirmed a causal link between specific gut microbiota and AP (15 and 8 microbial taxa identified via forward and reverse MR, respectively). The 16S rRNA sequencing analysis demonstrated a pronounced difference in gut microbiota composition between cases and controls. Notably, after a comprehensive evaluation of the results of RF and SVM, Bacteroides plebeius (B. plebeius) was found to play a significant role in influencing the hospital status. Using a receiver operating characteristic (ROC) curve, the predictive power (0.757) of B. plebeius. Kaplan–Meier survival analysis offered further insight that patients with an elevated abundance of B. plebeius experienced prolonged hospital stays.Conclusion: Combining MR with nested case–control studies provided a detailed characterization of interactions between gut microbiota and AP. B. plebeius was identified as a significant contributor, suggesting its role as both a precursor and consequence of AP dynamics. The findings highlight the multifactorial nature of AP and its complex relationship with the gut microbiota. This study lays the groundwork for future therapeutic interventions targeting microbial dynamics in AP treatment.
- 3 July 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1401056
Open AccessUnravelling the role of gut microbiota in acute pancreatitis: integrating Mendelian randomization with a nested case–control study
Background: Gut microbiota may influence the development of acute pancreatitis (AP), a serious gastrointestinal disease with high morbidity and mortality. This study aimed to identify a causal link by investigating the relationship between gut microbiota and AP.Methods: Mendelian randomization (MR) and a nested case–control study were used to explore associations between gut microbiota composition and AP. 16S rRNA sequencing, random forest modelling (RF), support vector machine (SVM), and Kaplan–Meier survival analysis was applied to identify significant gut microbiota and their correlation with hospitalization duration in AP patients.Results: Bidirectional MR results confirmed a causal link between specific gut microbiota and AP (15 and 8 microbial taxa identified via forward and reverse MR, respectively). The 16S rRNA sequencing analysis demonstrated a pronounced difference in gut microbiota composition between cases and controls. Notably, after a comprehensive evaluation of the results of RF and SVM, Bacteroides plebeius (B. plebeius) was found to play a significant role in influencing the hospital status. Using a receiver operating characteristic (ROC) curve, the predictive power (0.757) of B. plebeius. Kaplan–Meier survival analysis offered further insight that patients with an elevated abundance of B. plebeius experienced prolonged hospital stays.Conclusion: Combining MR with nested case–control studies provided a detailed characterization of interactions between gut microbiota and AP. B. plebeius was identified as a significant contributor, suggesting its role as both a precursor and consequence of AP dynamics. The findings highlight the multifactorial nature of AP and its complex relationship with the gut microbiota. This study lays the groundwork for future therapeutic interventions targeting microbial dynamics in AP treatment.
- 20 November 2023
- Published by Elsevier in European Journal of Pharmacology
- Vol. 961, 176193
Glycyrrhetinic acid attenuates endoplasmic reticulum stress-induced hepatocyte apoptosis via CHOP/DR5/Caspase 8 pathway in cholestasis
- 20 November 2023
- Published by Elsevier in European Journal of Pharmacology
- Vol. 961, 176193
Glycyrrhetinic acid attenuates endoplasmic reticulum stress-induced hepatocyte apoptosis via CHOP/DR5/Caspase 8 pathway in cholestasis
- Open Access
- 31 October 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (10) , 113262
Virus-induced lncRNA-BTX allows viral replication by regulating intracellular translocation of DHX9 and ILF3 to induce innate escape
- 31 October 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (10) , 113262
Open AccessVirus-induced lncRNA-BTX allows viral replication by regulating intracellular translocation of DHX9 and ILF3 to induce innate escape
- Open Access
- 6 September 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (9) , 1-13
Lysine methyltransferase SMYD2 inhibits antiviral innate immunity by promoting IRF3 dephosphorylation
S: Phosphorylation of IRF3 is critical to induce type I interferon (IFN-I) production in antiviral innate response. Here we report that lysine methyltransferase SMYD2 inhibits the expressions of IFN-I and proinflammatory cytokines in macrophages upon viral infections. The Smyd2-deficient mice are more resistant to viral infection by producing more IFN-I and proinflammatory cytokines. Mechanistically, SMYD2 inhibits IRF3 phosphorylation in macrophages in response to viral infection independent of its methyltransferase activity. We found that SMYD2 interacts with the DNA-binding domain (DBD) and IRF association domain (IAD) domains of IRF3 by its insertion SET domain (SETi) and could recruit phosphatase PP1α to enhance its interaction with IRF3, which leads to decreased phosphorylation of IRF3 in the antiviral innate response. Our study identifies SMYD2 as a negative regulator of IFN-I production against virus infection. The new way of regulating IRF3 phosphorylation will provide insight into the understanding of IFN-I production in the innate response and possible intervention of the related immune disorders.
- 6 September 2023
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (9) , 1-13
Open AccessLysine methyltransferase SMYD2 inhibits antiviral innate immunity by promoting IRF3 dephosphorylation
S: Phosphorylation of IRF3 is critical to induce type I interferon (IFN-I) production in antiviral innate response. Here we report that lysine methyltransferase SMYD2 inhibits the expressions of IFN-I and proinflammatory cytokines in macrophages upon viral infections. The Smyd2-deficient mice are more resistant to viral infection by producing more IFN-I and proinflammatory cytokines. Mechanistically, SMYD2 inhibits IRF3 phosphorylation in macrophages in response to viral infection independent of its methyltransferase activity. We found that SMYD2 interacts with the DNA-binding domain (DBD) and IRF association domain (IAD) domains of IRF3 by its insertion SET domain (SETi) and could recruit phosphatase PP1α to enhance its interaction with IRF3, which leads to decreased phosphorylation of IRF3 in the antiviral innate response. Our study identifies SMYD2 as a negative regulator of IFN-I production against virus infection. The new way of regulating IRF3 phosphorylation will provide insight into the understanding of IFN-I production in the innate response and possible intervention of the related immune disorders.
- Open Access
- 19 July 2023
- Published by Wiley
Investigating the Causal Links between COVID-19 and Pancreatitis by Bidirectional Mendelian Randomization
Objective The immune response is a double-edged sword, and COVID-19 shares similarities with pancreatitis in terms of natural immune response, immune storm, and multi-organ involvement. However, whether a causal association between them remained unclear. This study aimed to investigate the potential causal association between COVID-19 and pancreatitis using a bidirectional Mendelian Randomization (MR) approach. Methods The study analyzed three variables related to COVID-19 (severity, hospitalization, and susceptibility) with a sample size ranging from approximately 1,059,456 to 1,557,411. Additionally, four types of pancreatitis (acute, chronic, alcohol-induced acute, and chronic) were examined, with a sample size ranging from 337,126 to 377,277. Causal associations were estimated using inverse-variance weighted (IVW), median weighted, and MR-Egger methods. Results The IVW model indicated potential causal associations between genetic susceptibility to severe and hospitalized COVID-19 and a decreased risk of acute pancreatitis (OR = 0.914, p = 0.01; OR = 0.884, p = 0.008) and alcohol-induced chronic pancreatitis (OR = 0.852, p = 0.013; OR = 0.768, p = 0.002), including chronic pancreatitis. Inconsistent associations were observed between IVW and sensitivity analyses in acute and chronic pancreatitis of severe and hospitalized COVID-19. Conversely, no significant associations were found between pancreatitis traits and COVID-19-related variables in reverse MR analysis. No heterogeneity or pleiotropy was found. Conclusions Host genetic liability to severe and hospitalized COVID-19 was causally associated with declining risk of alcohol-induced chronic pancreatitis, while no significant association was observed for pancreatitis on COVID-19 outcomes. This study has significant implications for unraveling their pathogenesis and guiding clinical management.
- 19 July 2023
- Published by Wiley
Open AccessInvestigating the Causal Links between COVID-19 and Pancreatitis by Bidirectional Mendelian Randomization
Objective The immune response is a double-edged sword, and COVID-19 shares similarities with pancreatitis in terms of natural immune response, immune storm, and multi-organ involvement. However, whether a causal association between them remained unclear. This study aimed to investigate the potential causal association between COVID-19 and pancreatitis using a bidirectional Mendelian Randomization (MR) approach. Methods The study analyzed three variables related to COVID-19 (severity, hospitalization, and susceptibility) with a sample size ranging from approximately 1,059,456 to 1,557,411. Additionally, four types of pancreatitis (acute, chronic, alcohol-induced acute, and chronic) were examined, with a sample size ranging from 337,126 to 377,277. Causal associations were estimated using inverse-variance weighted (IVW), median weighted, and MR-Egger methods. Results The IVW model indicated potential causal associations between genetic susceptibility to severe and hospitalized COVID-19 and a decreased risk of acute pancreatitis (OR = 0.914, p = 0.01; OR = 0.884, p = 0.008) and alcohol-induced chronic pancreatitis (OR = 0.852, p = 0.013; OR = 0.768, p = 0.002), including chronic pancreatitis. Inconsistent associations were observed between IVW and sensitivity analyses in acute and chronic pancreatitis of severe and hospitalized COVID-19. Conversely, no significant associations were found between pancreatitis traits and COVID-19-related variables in reverse MR analysis. No heterogeneity or pleiotropy was found. Conclusions Host genetic liability to severe and hospitalized COVID-19 was causally associated with declining risk of alcohol-induced chronic pancreatitis, while no significant association was observed for pancreatitis on COVID-19 outcomes. This study has significant implications for unraveling their pathogenesis and guiding clinical management.